Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.

Drug coverage for four drugs used to treat some rare diseases was announced in Fredericton on Wednesday under a $32 million deal signed by the federal and provincial governments. Under the ...

It's important not to overuse headache medications, as it can lead to new or worse symptoms. Your doctor can help you understand different headache treatments and how to use them safely.

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

There is no single best antipsychotic medication for bipolar disorder, as there is no one-size-fits-all solution for everyone with this condition. The best choice depends on the type of bipolar ...

Anticonvulsants are first-line medications that help manage the symptoms of seizure disorders, such as epilepsy. As a 2023 review explains, these drugs can work in various ways. One important ...

Treating eosinophilic chronic obstructive pulmonary disease (COPD) with monoclonal antibodies significantly reduces exacerbations and has an acceptable safety and tolerability profile compared with ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, with 66 percent of people in ...

Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for exceptional importation and sale are called "designated drugs".

“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.